Form 4: Quest Diagnostics Executive Sam Samad Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Executive Vice President & CFO of Quest Diagnostics, Sam Samad, disposed of 1,031 shares of common stock to cover tax withholding obligations arising from the vesting of restricted stock units.
Summary
- On February 19, 2025, Sam Samad, Executive Vice President & CFO of Quest Diagnostics, disposed of 1,031 shares of common stock.
- The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The price per share was $169.71.
- Following the transaction, Samad directly owns 21,046 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, and doesn't indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of executive compensation and are common across publicly traded companies. This transaction reflects standard practice for covering tax obligations related to equity compensation.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date of transaction: Sam Samad disposed of 1,031 shares of common stock to cover tax obligations. |
| 02/21/2025 | Date of signature: Sean D. Mersten, Attorney in Fact for Sam Samad, signed the Form 4. |
Keywords
Quest Diagnostics, Sam Samad, Form 4, Executive Vice President, CFO, Share Disposal, Tax Withholding, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.